Sunday, May 28, 2017

Pharma Reviews: Transfer of IP assets by pharma firms to abroad under RBI scrutiny

MUMBAI: For years, many pharma companies in India have been moving their intellectual property (IP) assets — the firms' prized possessions — to ...
Read more: Transfer of IP assets by pharma firms to abroad under RBI scrutiny